Most Read News

MMTC reported a consolidated net profit of Rs 118.38 crore in Q1 FY23 as against a net loss of Rs 597.17 crore in Q1 FY22.

The drug will be manufactured at the group’s formulation facility at SEZ, Ahmedabad, India.

The headline equity indices traded in a narrow range with moderate losses in the mid-morning trade. The Nifty hovered a tad below the 16,160 mark. Pharma shares extended gains for fifth consecutive trading session. At 11:28 IST, the barometer index, the S&P BSE Sensex, was down 271.62 points or 0.50% to 54,210.22. The Nifty 50 index declined 66.25 points or 0.41% to 16,154.35. In the […]

The drug maker announced that it has received final approval from the US-based drug regulator to market Empagliflozin and Metformin Hydrochloride tablets in multiple strengths.

A sharp decline in commodities, particularly palm oil, which may result in a few months of "unexpectedly low" food inflation, would be welcomed by policymakers and consumers in India.

With effect from 11 July 2022

The Buildings & Factories (B&F) Business of L&T Construction has received contracts from a number of important clients.

Additionally, the startup and Woodside Energy Technologies have agreed to a strategic development plan to reduce greenhouse gases by turning carbon into valuable products.

The customers can book the Grand Vitara via an initial payment of Rs11,000.

Additionally, Paytm reached 76 million monthly active users on the Super App in June, which is a record high.